Recent clinical advances with camptothecin analogues.
作者信息
Slichenmyer W J, Donehower R C
机构信息
Johns Hopkins Oncology Center, Baltimore, MD 21287, USA.
出版信息
Cancer Treat Res. 1995;78:29-43. doi: 10.1007/978-1-4615-2007-8_2.
PMID:8595145
Abstract
摘要
相似文献
1
Recent clinical advances with camptothecin analogues.喜树碱类似物的近期临床进展。
Cancer Treat Res. 1995;78:29-43. doi: 10.1007/978-1-4615-2007-8_2.
2
Topoisomerase I inhibitors: topotecan and irenotecan.拓扑异构酶I抑制剂：拓扑替康和伊立替康。
Cancer Treat Rev. 1994 Jan;20(1):73-96. doi: 10.1016/0305-7372(94)90011-6.
3
Camptothecin analogues: studies from the Johns Hopkins Oncology Center.喜树碱类似物：来自约翰霍普金斯肿瘤中心的研究
Cancer Chemother Pharmacol. 1994;34 Suppl:S53-7. doi: 10.1007/BF00684864.
4
Clinical studies of camptothecin and derivatives.喜树碱及其衍生物的临床研究。
Alkaloids Chem Biol. 2003;60:1-50. doi: 10.1016/s0099-9598(03)60001-5.
5
Topoisomerase I inhibitors: topotecan and irinotecan.拓扑异构酶I抑制剂：拓扑替康和伊立替康。
Cancer Pract. 1996 Jan-Feb;4(1):51-3.
6
Topoisomerase I inhibition: a new target or new missiles?
Ann Oncol. 1995 Feb;6(2):102-4. doi: 10.1093/oxfordjournals.annonc.a059100.
7
Irinotecan (CPT-11): pharmacology and clinical applications.伊立替康（CPT - 11）：药理学与临床应用
Crit Rev Oncol Hematol. 1996 Sep;24(1):3-26. doi: 10.1016/1040-8428(96)00201-6.
8
Irinotecan hydrochloride.
Clin J Oncol Nurs. 2001 Jul-Aug;5(4):179-80, 184.
9
Design, synthesis and development of novel camptothecin drugs.新型喜树碱类药物的设计、合成与开发
Curr Pharm Des. 2008;14(11):1078-97. doi: 10.2174/138161208784246180.
10
A review of the clinical experience with irinotecan (CPT-11).
Am J Ther. 1997 May-Jun;4(5-6):203-10. doi: 10.1097/00045391-199705000-00007.
Zotero 插件